The government failed to secure enough supplies early
Responsibility avoidance issuance while advocating safety
Experts “Introduction first is aggressively
Safety is a matter to highlight at the time of vaccination”
On the 22nd (local time), officials from the virus research institute in Belgrade, Serbia, are unloading the first amount of Pfizer-Bioentech’s Corona 19 vaccine from a truck. Belgrade Reuters = Yonhap News
The government was not in a hurry to negotiate to secure a vaccine at the beginning of the corona19 epidemic, and this is raising anxiety over whether the timing of introducing a sufficient amount of vaccine in Korea is unclear. Eventually, the situation is spreading into a political dispute asking the Blue House, the government, and the ruling party to be responsible. Accordingly, the government actively defended itself, saying that checking’vaccine safety’ is a priority. However, experts on infectious diseases pointed out that vaccine safety is a matter that should be highlighted at the time of vaccination, not at the time of introduction, and pointed out whether the government is urgently only evading responsibility when criticism of’procrastination’ has risen. On the 23rd, Sohn Young-rae, head of the Strategic Planning Division of the Central Accident Recovery Headquarters (heavy water version), at a regular briefing, said, “As a quarantine authority, we express a great deal of concern over the creation of a social atmosphere that seems to be competing for the first place, as if it is the first in the world to get a vaccine.” Revealed. He continued, “The development process for the Corona 19 vaccine is significantly shortened, so safety (verification) is important. I am very fortunate to have the opportunity to observe problems occurring in the country where the vaccination is first given for a month or two.” In a situation where doubts are growing over the time of introduction of the vaccine in Korea, he brought out the’dong document answer’ that’the vaccination may be a little late.’ The government previously announced that it has secured a vaccine for 44 million people through COVAX Facility, an international organization for joint vaccine purchase, and overseas pharmaceutical companies AstraZeneca, Pfizer, Modena, and Janssen. However, the timing of introduction in Korea is specified from February to March next year, and AstraZeneca is the only vaccine that has completed a purchase contract. The government plans to conclude an actual contract with Pfizer and Janssen in this month and with Modena in January of next year, but it is difficult to disclose the timing of introduction due to confidentiality provisions with individual pharmaceutical companies. Some media reported that’out of the 10 million AstraZeneca vaccine supplies, only 750,000 are supplied in February and March’, the same reason was closed. Despite such a situation, the government seems to move away from the controversy by re-emphasizing only that the situation in the United States, Europe and Korea was different. “In fact, there are not many quarantine strategies that can be adopted other than vaccines in countries such as the United States, so we have been putting all our efforts into vaccines,” said Son, dismissed, saying, “It is somewhat inappropriate for us to take these countries as teachers on the other hand.” . However, since it is not known when the peak of the third epidemic is now unknown, it seems difficult for the government to alleviate public anxiety only by emphasizing’safety check’. Choi Won-seok, a professor at Korea University’s Ansan Hospital (infectious medicine department), said, “There have been no reports of adverse side effects that are serious enough to stop vaccination during the overseas vaccination process.” It is not a problem that determines the timing of vaccination, so it is appropriate to be aggressive in introduction.” He added, “Recently, critics of the government often seem to be questioning the safety of AstraZeneca vaccines, and governments and ruling parties are often concerned about the safety of vaccines from other pharmaceutical companies.” “If the vaccine politics leads to a decline in safety confidence, the avoidance of specific vaccines “It can happen, and as a result, even the most difficult vaccines can be used.” Some suggest that the government should be able to properly evaluate the response so far, so that future vaccine introduction plans should be made more aggressive. Eom Joong-sik, a professor at Gachon University’s Gil Hospital (infectious medicine department), said, “We need to have the government’s decision-making structure, legal and institutional mechanisms, and the authority to secure budgets that can boldly pre-purchase vaccines under development, so that future vaccine introduction negotiations will be easier I will.” By Choi Ha-yan, staff reporter [email protected]